Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2024.115197 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Jeanne Lena und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Institut Bergonié, Bordeaux, France. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinoma, Pancreatic Ductal, Mutation, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Institut Bergonié, Bordeaux, France.
- Department of Pathology, Institut Bergonié, Bordeaux, France.
- Department of Medicine, Institut Bergonié, Bordeaux, France; Faculty of Medicine, University of Bordeaux, France.
- Department of Medicine, Institut Bergonié, Bordeaux, France. Electronic address: l.palmieri@bordeaux.unicancer.fr.
Zitieren
APA
Lena, J., Alamé, M., Italiano, A., Soubeyran, I., Blouin, L., Khalifa, E., Cousin, S., Pernot, S., & Palmieri, L. J. (2025). Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115197
Vancouver
Lena J, Alamé M, Italiano A, Soubeyran I, Blouin L, Khalifa E, et al. Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115197
BibTeX
@article{Lena2025,
author = {Lena, Jeanne and Alamé, Mélissa and Italiano, Antoine and Soubeyran, Isabelle and Blouin, Laura and Khalifa, Emmanuel and Cousin, Sophie and Pernot, Simon and Palmieri, Lola-Jade},
title = {Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2024.115197}
}
EUVIMED